PMID- 27023007
OWN - NLM
STAT- MEDLINE
DCOM- 20170303
LR  - 20170303
IS  - 1439-3646 (Electronic)
IS  - 0947-7349 (Linking)
VI  - 124
IP  - 8
DP  - 2016 Sep
TI  - Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of 
      Changing Disease Prevalence and its Pandemic Impact to Qatar.
PG  - 504-511
AB  - Background: The Middle East region is predicted to have one of the highest 
      prevalence of diabetes mellitus (DM) in the world. The risk of diabetes continues 
      to increase worldwide and its public health burden is unevenly distributed across 
      socioeconomic strata. This burden is not only related to health care costs, but 
      also to indirect costs caused by loss of productivity from disability and 
      premature mortality. Aim: This study aims to estimate the economics cost of type 
      2 Diabetes Mellitus [T2DM] among adults in Qatar using national data, and to 
      quantify the potential effect of a suggested preventive intervention program. 
      Design: It is an observational cohort study. Setting: The survey was based on 
      registry at the Hamad General Hospital and Primary Health Care (PHC) centers in 
      the State of Qatar. Subject: This study consisted of patients above 25 years of 
      age with diagnosed diabetes mellitus registered at Hamad General Hospital and 
      Primary Health Care (PHC) centers during January 2004 to July 2014. Methods: We 
      developed a dynamic model in which actual incidence, prevalence, and life 
      expectancy data are used and alternative assumptions about future trends in these 
      parameters can be incorporated. Linear regression model has been performed to 
      forecast the burden of diabetes in oil-rich country. Results: According to the 
      dynamic model, a 10% increased in the number of diabetic patients in the State of 
      Qatar from 33 610 in 2005 to 122 000 in 2012 (about 1% annually). The annual 
      diabetes incidence rate was higher in women than in men during a period between 
      2005 to 2015 years. The static model forecasted as 10% increase over 10 years. 
      The relative increase in prevalence of diabetes and number of diabetic people are 
      higher in women than in men (16.6%; 17.5% and 18.4% in men vs. 22.6%; 23.8% and 
      25.1% in women). Most of the increase in prevalence of diabetes is projected to 
      occur in younger age groups where it is estimated to increase among age groups of 
      50-59 years and above 60 years, respectively. Conclusion: The burden of diabetes 
      in Qatar is markedly larger than proposed by IDF estimations - suggesting that 
      Qatar would be one of the top 10 countries worldwide in diabetes prevalence. 
      Family history of diabetes, consanguinity marriages', hereditary gene-environment 
      interactions, poor nutrition in utero and in early life plus over nutrition in 
      later life may also contribute to the current diabetes epidemic in Qatari's Arab 
      populations. Finally, continuous training of primary health care professionals on 
      diabetes care and prevention is an essential tool of improving diabetes in Qatar.
CI  - (c) Georg Thieme Verlag KG Stuttgart . New York.
FAU - Bener, A
AU  - Bener A
AD  - Department of Biostatistics & Medical Informatics, Cerrahpasa Faculty of 
      Medicine, Istanbul University, Istanbul, Turkey.
FAU - Al-Hamaq, A O A A
AU  - Al-Hamaq AO
AD  - Qatar Diabetic Association and Qatar Foundation, Doha, State of Qatar.
LA  - eng
PT  - Journal Article
DEP - 20160329
PL  - Germany
TA  - Exp Clin Endocrinol Diabetes
JT  - Experimental and clinical endocrinology & diabetes : official journal, German 
      Society of Endocrinology [and] German Diabetes Association
JID - 9505926
SB  - IM
MH  - Adult
MH  - *Cost of Illness
MH  - *Databases, Factual
MH  - Diabetes Mellitus, Type 2/*economics/*epidemiology/therapy
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Models, Economic
MH  - Predictive Value of Tests
MH  - Prevalence
MH  - Qatar/epidemiology
EDAT- 2016/03/30 06:00
MHDA- 2017/03/04 06:00
CRDT- 2016/03/30 06:00
PHST- 2016/03/30 06:00 [pubmed]
PHST- 2017/03/04 06:00 [medline]
PHST- 2016/03/30 06:00 [entrez]
AID - 10.1055/s-0042-103683 [doi]
PST - ppublish
SO  - Exp Clin Endocrinol Diabetes. 2016 Sep;124(8):504-511. doi: 
      10.1055/s-0042-103683. Epub 2016 Mar 29.